Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 548470-11-7 | MDL No. : | MFCD27952932 |
Formula : | C22H24Cl2N2O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HJGMCDHQPXTGAV-UHFFFAOYSA-N |
M.W : | 451.34 | Pubchem ID : | 1011240 |
Synonyms : |
|
Num. heavy atoms : | 30 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.36 |
Num. rotatable bonds : | 10 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 116.12 |
TPSA : | 76.66 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.62 cm/s |
Log Po/w (iLOGP) : | 3.43 |
Log Po/w (XLOGP3) : | 4.84 |
Log Po/w (WLOGP) : | 3.99 |
Log Po/w (MLOGP) : | 2.69 |
Log Po/w (SILICOS-IT) : | 4.15 |
Consensus Log Po/w : | 3.82 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -5.32 |
Solubility : | 0.00214 mg/ml ; 0.00000475 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -6.18 |
Solubility : | 0.000296 mg/ml ; 0.000000655 mol/l |
Class : | Poorly soluble |
Log S (SILICOS-IT) : | -7.52 |
Solubility : | 0.0000137 mg/ml ; 0.0000000304 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 3.0 |
Synthetic accessibility : | 3.32 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
[ 551952-55-7 ]
N-(2-(2,4,6-Trichlorophenoxy)ethyl)propan-1-amine hydrochloride
Similarity: 0.70
[ 223251-25-0 ]
1-(2-(4-(Chloromethyl)phenoxy)ethyl)azepane hydrochloride
Similarity: 0.62
[ 17199-34-7 ]
1-(3,5-Dichlorophenoxy)propan-2-one
Similarity: 0.61
[ 41859-57-8 ]
4-Chloro-N-(4-hydroxyphenethyl)benzamide
Similarity: 0.60
[ 27320-99-6 ]
7-Chloro-2H-benzo[b][1,4]oxazin-3(4H)-one
Similarity: 0.71
[ 551952-55-7 ]
N-(2-(2,4,6-Trichlorophenoxy)ethyl)propan-1-amine hydrochloride
Similarity: 0.70
[ 26494-58-6 ]
2-(6-Chloro-3-oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl)acetic acid
Similarity: 0.65
[ 223251-25-0 ]
1-(2-(4-(Chloromethyl)phenoxy)ethyl)azepane hydrochloride
Similarity: 0.62
[ 17199-34-7 ]
1-(3,5-Dichlorophenoxy)propan-2-one
Similarity: 0.61
[ 551952-55-7 ]
N-(2-(2,4,6-Trichlorophenoxy)ethyl)propan-1-amine hydrochloride
Similarity: 0.70
[ 223251-25-0 ]
1-(2-(4-(Chloromethyl)phenoxy)ethyl)azepane hydrochloride
Similarity: 0.62
[ 17199-34-7 ]
1-(3,5-Dichlorophenoxy)propan-2-one
Similarity: 0.61
[ 588-22-7 ]
2-(3,4-Dichlorophenoxy)acetic acid
Similarity: 0.60
[ 27320-99-6 ]
7-Chloro-2H-benzo[b][1,4]oxazin-3(4H)-one
Similarity: 0.71
[ 26494-58-6 ]
2-(6-Chloro-3-oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl)acetic acid
Similarity: 0.65
[ 129385-59-7 ]
trans-11-Chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrol-1-one
Similarity: 0.61
[ 1272966-06-9 ]
(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)(3-hydroxypyrrolidin-1-yl)methanone
Similarity: 0.60
[ 551952-55-7 ]
N-(2-(2,4,6-Trichlorophenoxy)ethyl)propan-1-amine hydrochloride
Similarity: 0.70
[ 41859-57-8 ]
4-Chloro-N-(4-hydroxyphenethyl)benzamide
Similarity: 0.60
[ 121-27-7 ]
5-Chloro-2-(4-chlorophenoxy)aniline
Similarity: 0.58